The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques

Contraception

Volumn 77, Issue 4, 2008, Pages 303-307

  Jensen, Jeffrey T ^a,b   Zelinski, Mary B ^b   Stanley, Jessica E ^b   Fanton, John W ^b   Stouffer, Richard L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Contraception; Macaque; Meiosis; Oocyte; Phosphodiesterase inhibitor

Indexed keywords

6 (5,6 DIMETHOXYBENZO[B]THIEN 2 YL) 4,5 DIHYDRO 5 METHYL 3(2H) PYRIDAZINONE; GONADOTROPIN; PHOSPHODIESTERASE III INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL INSEMINATION; CONTRACEPTION; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; FOLLICULAR PHASE; LAPAROSCOPY; MEIOSIS; NONHUMAN; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVULATION; PROGESTERONE BLOOD LEVEL; RHESUS MONKEY; STATISTICAL ANALYSIS;

ANIMALS; CONTRACEPTIVE AGENTS, FEMALE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; FEMALE; MACACA MULATTA; MEIOSIS; OOCYTES; OVULATION; PHOSPHODIESTERASE INHIBITORS; THIOPHENES;

EID: 40649099783     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.01.003     Document Type: Article

References (21)

1. Chandra A., Martinez G.M., Mosher W.D., et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat (2005) 1-160
2. Finer L.B., and Henshaw S.K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 38 (2006) 90-96
3. Peipert J.F., and Gutmann J. Oral contraceptive risk assessment: a survey of 247 educated women. Obstet Gynecol 82 (1993) 112-117
4. Tsafriri A., Chun S.Y., Zhang R., et al. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol (Orlando) 178 (1996) 393-402
5. Conti M., Andersen C.B., Richard F.J., et al. Role of cyclic nucleotide phosphodiesterases in resumption of meiosis. Mol Cell Endocrinol 145 (1998) 9-14
6. Mayes M.A., and Sirard M.A. Effect of type 3 and type 4 phosphodiesterase inhibitors on the maintenance of bovine oocytes in meiotic arrest. Biol Reprod 66 (2002) 180-184
7. Conti M., Andersen C.B., Richard F., et al. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol 187 (2002) 153-159
8. Wiersma A., Hirsch B., Tsafriri A., et al. Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents. J Clin Invest 102 (1998) 532-537
9. Jensen J.T., Schwinof K.M., Zelinski-Wooten M.B., et al. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro. Hum Reprod 17 (2002) 2079-2084
10. Nogueira D., Albano C., Adriaenssens T., et al. Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod 69 (2003) 1042-1052
11. Jensen J.T., Zelinski-Wooten M.B., Schwinof K.M., et al. The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques. Contraception 71 (2005) 68-73
12. Stouffer R.L., and Zelinski-Wooten M.B. Overriding follicle selection in controlled ovarian stimulation protocols: quality vs quantity. Reprod Biol Endocrinol 2 (2004) 32
13. Young K.A., Chaffin C.L., Molskness T.A., et al. Controlled ovulation of the dominant follicle: a critical role for LH in the late follicular phase of the menstrual cycle. Hum Reprod 18 (2003) 2257-2263
14. Jensen J.T., Stanley J.E., Zelinski M.B., et al. Use of controlled ovulation of the dominant follicle to assess oocyte maturation during natural menstrual cycles in rhesus macaques. Fertil Steril 87 (2007) 1477-1479
15. Wolf D.P., Thomson J.A., Zelinski-Wooten M.B., et al. In vitro fertilization-embryo transfer in nonhuman primates: The technique and its applications. Mol Reprod Dev 27 (1990) 261-280
16. Zelinski-Wooten M.B., Hutchison J.S., Trinchard-Lugan I., et al. Initiation of periovulatory events in gonadotrophin-stimulated macaques with varying doses of recombinant human chorionic gonadotrophin. Hum Reprod 12 (1997) 1877-1885
17. Young K.A., Hennebold J.D., and Stouffer R.L. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Mol Hum Reprod 8 (2002) 833-840
18. Hibbert M.L., Stouffer R.L., Wolf D.P., et al. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci U S A 93 (1996) 1897-1901
19. Zelinski-Wooten M.B., Lanzendorf S.E., Wolf D.P., et al. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function. J Clin Endocrinol Metab 73 (1991) 577-583
20. Wolf D.P., Vandevoort C.A., Meyer-Haas G.R., et al. In vitro fertilization and embryo transfer in the rhesus monkey. Biol Reprod 41 (1989) 335-346
21. Vanhoutte L., De Sutter P., Nogueira D., et al. Nuclear and cytoplasmic maturation of in vitro matured human oocytes after temporary nuclear arrest by phosphodiesterase 3-inhibitor. Hum Reprod 22 (2007) 1239-1246